HematoCare: Feasibility of a Survivorship Care Plan for Hematologic Cancer Patients Undergoing HSCT

Recruiting now · Not applicable

Conditions studied: Hematologic Neoplasm, Hematopoietic Stem Cell Transplantation, Survivorship, Cancer Survivorship

In brief

This is a feasibility study to implement a Survivorship Care (SC) Plan for patients with hematologic cancer undergoing hematopoietic stem cell transplantation (HSCT). The study evaluates if the intervention is feasible within the Italian national health system, focusing on retention rates, quality of life, unmet needs and caregiver burden

Key facts

Study ID

NCT07579065

Run by

Azienda USL Reggio Emilia - IRCCS

People needed

40

Starts

2026-06-01

Expected to finish

2028-01-01

Last updated by the study team

2026-07-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with hematologic cancer candidates for HSCT (autologous or allogeneic) and their informal caregivers
• Able to provide informed consent
• Able to communicate in Italian

You may not qualify if…

• Patients or caregivers with comorbidities hindering participation (e.g., significant cognitive limitations)

Where it is running

• Research and EBP Unit, Azienda USL-IRCCS di Reggio Emilia — Reggio Emilia, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.